As of Mar 31, 2025
Invesco Pharmaceuticals ETF (ARCA: PJP)
Ticker | Name | Share % | |
---|---|---|---|
ABBV | Abbvie Inc | 5.17% | |
JNJ | Johnson & Johnson | 5.03% | |
PFE | Pfizer Inc | 4.77% | |
AMGN | Amgen Inc | 4.97% | |
REGN | Regeneron Pharmaceuticals, Inc. | 6.08% | |
ABT | Abbott Laboratories | 4.92% | |
LLY | Eli Lilly & Co | 4.61% | |
MRK | Merck & Co Inc | 4.94% | |
GERN | Geron Corp | 4.77% | |
LGND | Ligand Pharmaceuticals Inc | 4.36% | |
BMY | Bristol-Myers Squibb Co. | 5.05% | |
LQDA | Liquidia Technologies Inc | 3.74% | |
GILD | Gilead Sciences Inc | 5.06% | |
CORT | Corcept Therapeutics Inc | 5.12% | |
TARS | Tarsus Pharmaceuticals Inc | 3.42% |
The PJP ETF is currently trading at $77.46, which represents a -0.31% change. Over the past 52 weeks, the ETF has traded as high as $89.87 and as low as $72.25.
The expense ratio of PJP is 0.56%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for PJP is 230.30M. This represents the total market value of the assets managed by the ETF.
PJP follows a Large Cap Value investment style.
The top holdings of PJP include: ABBV (5.17%), JNJ (5.03%), PFE (4.77%), AMGN (4.97%), REGN (6.08%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for PJP is currently not available.